Low sodium levels are linked to how patients with short bowel syndrome respond to glepaglutide

Glepaglutide is associated with reduced need for parenteral support in patients with short-bowel syndrome.

• The study examined the relationship between sodium levels in urine and changes in parenteral support.
• Patients receiving glepaglutide showed improvements in nutrient absorption, including sodium.
• Glepaglutide may positively influence sodium homeostasis in individuals with short-bowel syndrome.

Simplified